Posted by Michael Wonder on 22 Jul 2019
Infants with cystic fibrosis to breathe easier with new PBS listing
22 July 2019 - The Australian Government is expanding access to a critically important medicine on the PBS that will help infants living with cystic fibrosis and save their families up to $300,000 per year.
From 1 August, the medicine Kalydeco (ivacaftor), will made available through the PBS for patients aged 12 to 24 months living with the condition.
